<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="4172">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 08, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04442243</url>
  </required_header>
  <id_info>
    <org_study_id>REK125510 (4)</org_study_id>
    <nct_id>NCT04442243</nct_id>
  </id_info>
  <brief_title>PTSD Symptoms Among Health Workers and Public Service Providers After the COVID-19 Outbreak: A 3 Month Follow up</brief_title>
  <official_title>PTSD Symptoms Among Health Workers and Public Service Providers After the COVID-19 Outbreak: A 3 Month Follow up</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Oslo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Modum Bad Psychiatric Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Oslo</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to investigate the levels of trauma and mental symptoms (i.e.,&#xD;
      depression and anxiety) among health workers and public service providers 3 months after (T2)&#xD;
      the strict social distancing government initiated non-pharmacological interventions (NPIs)&#xD;
      related to the COVID-19 pandemic (T1), in a period of lifted distancing protocols. The study&#xD;
      also aims to investigate predictors of trauma-symptoms, by analyzing how predictors measured&#xD;
      during the COVID-19 pandemic are associated with change in PTSD symptoms from T1 to T2.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Hypotheses/Research questions:&#xD;
&#xD;
      H1: There will be a significant decrease in PTSD-symptoms, anxiety and depression from T1 to&#xD;
      T2.&#xD;
&#xD;
      Exploratory: Examine the differences in levels of trauma, anxiety, depression and quality of&#xD;
      life among different health workers, public service providers, demographic subgroups, and&#xD;
      between those working directly vs indirectly with COVID-19 patients at T2. Examine the&#xD;
      differences in change of trauma, anxiety and depression among different health workers,&#xD;
      public service providers, demographic subgroups, and between those working directly vs&#xD;
      indirectly with COVID-19 patients.&#xD;
&#xD;
      H2: Higher level at T1 and less reduction from T1 to T2 in metacognition, strategies,&#xD;
      burnout, worry about job and economy, interpersonal problems at baseline will be associated&#xD;
      with less reduction in PTSD-symptom from T1 to T2, above and beyond direct vs. indirect&#xD;
      exposure to trauma, demographic variables (age and gender, living with a partner, living with&#xD;
      children).&#xD;
&#xD;
      This study is part of 'The Norwegian COVID-19, Mental Health and Adherence Project',&#xD;
      involving multiple studies.&#xD;
&#xD;
      Sample size The sample size at T1 was 1778 participants. The sample size at T2 is not yet&#xD;
      clarified, but we expect 50% drop out.&#xD;
&#xD;
      Sample size rationale The mentioned 'Norwegian COVID-19 and Mental Health and Adherence&#xD;
      Project' involves multiple studies, where some involve a Complex Systems (Network analysis&#xD;
      approach). These multivariate analyses require large samples and power analysis was conducted&#xD;
      accordingly. Following power analysis guidelines by Fried &amp; Cramer (2017), it is recommended&#xD;
      that the number of participants be at the very least three times larger than the number of&#xD;
      estimated parameters. However, more conservative recommendations by Roscoe (1975) for&#xD;
      multivariate research, recommends sample size that is ten times larger than the number of&#xD;
      estimated parameters.&#xD;
&#xD;
      Stopping rule:&#xD;
&#xD;
      The data collection will start at June 22th and continue until as many as possible of 1778&#xD;
      respondents at T1 have submitted the questionnaire. The data-collection at T2 will be stopped&#xD;
      after three weeks.&#xD;
&#xD;
      Indices:&#xD;
&#xD;
      Given Acceptable Cronbach's alpha (above 0.7) two items was combined to represent worry about&#xD;
      work and economy. On the CAS1 four items were combined into the subscale &quot;positive&#xD;
      metacognition&quot;, four items were combined into the subscale &quot;negative metacognition&quot;, and 8&#xD;
      items were combined into the subscale strategies (Nordahl &amp; Wells, 2019). Interpersonal&#xD;
      problems consisted of 17 items selected from the IIP-64. Burnout was measured with a single&#xD;
      item. Worry about job and economy were measured with two time-points.&#xD;
&#xD;
      Statistical models:&#xD;
&#xD;
      Descriptive statistics with frequency tables including N, mean and SDs or median and&#xD;
      interquartile range depending on the data will be presented. A cut-off of 31 on the PCL-5&#xD;
      will be used together with the DSM-5 diagnostic guidelines applied to the PCL-5 to categorize&#xD;
      participants as fulfilling the PTSD symptom criteria or not. Participants indicating scores&#xD;
      of 2 or above on at least one of five re-experiencing symptoms, one of two avoidance&#xD;
      symptoms, two of seven symptoms of negative alterations in cognition and mood and two of six&#xD;
      arousal symptoms were classified as fulfilling the PTSD symptom criteria. Subclinical PTSD&#xD;
      will be assessed by specifying how large part of the sample which fulfill parts of the&#xD;
      PTSD-criterias, more specifically have at least one symptom above threshold (2 or above) in&#xD;
      each symptom-group. The results will be benchmarked against national and international&#xD;
      studies.&#xD;
&#xD;
      For PHQ-9, scores above 10 are considered as cut-off indicating that the patient is within&#xD;
      the depressive area.&#xD;
&#xD;
      For GAD-7 a cut-off of 8 and above will be used.&#xD;
&#xD;
      Paired sample t-test or paired samples Wilcoxon Test will be used to compare the&#xD;
      PTSD-symptoms at T2, depending on the nature of the data.&#xD;
&#xD;
      A One-way ANOVA or Kruskal-Wallis test, depending on level of skewness, will be conducted to&#xD;
      exploratory investigate differences between the different types of health-workers (e.g.&#xD;
      medical doctor and clinical psychologists) and public service providers (e.g., politicians,&#xD;
      social security), working directly vs indirectly. If there is significant differences between&#xD;
      the groups the investigators will either use a post hoc test, Tukey (HSD) or Dunn-Bonferroni,&#xD;
      depending on wether a parametric or non-parametric test has been used.&#xD;
&#xD;
      Repeated surveys like the present one typically have a lot of drop out and missing data.&#xD;
      Therefore, we will use mixed models instead of paired t-tests, repeated measures ANOVAs, and&#xD;
      ordinary linear regression to analyze the majority of the data. Mixed models use maximum&#xD;
      likelihood estimation, which is the state of the art approach to handle missing data (Schafer&#xD;
      &amp; Graham, 2002). Especially if data are missing at random, which is likely in our survey,&#xD;
      mixed models give more unbiased results than the other analytic methods (O'Connel et al.,&#xD;
      2017).&#xD;
&#xD;
      In preliminary analyses, and for each of the dependent variables (PCL-5, GAD-7 and PHQ-9),&#xD;
      the combination of random effects and covariance structure of residuals that gives the best&#xD;
      fit for the &quot;empty&quot; model (the model without fixed predictors except the intercept) will be&#xD;
      chosen. Akaike's Information Criterion (AIC) will used to compare the fit of different&#xD;
      models. Models that give a reduction in AIC greater than 2 will be considered better (Burnham&#xD;
      &amp; Anderson, 2004). The program SPSS 25.0 will be used (IBM Corp, 2018).&#xD;
&#xD;
      First, H1 about decrease in PCL-5, GAD-7 and PHQ-9 will be tested by using anxiety or&#xD;
      depression as dependent variable in a model using time (T1 period = 0, T2 period = 1) as a&#xD;
      predictor. Second, demographic group variables will be added as predictors. Third, the&#xD;
      initial (T1) levels of metacognition, strategies, burnout, worry about job and economy,&#xD;
      interpersonal problems will be added, together with the interactions of these constant&#xD;
      covariates with time. These interactions represent tests of H2 about the covariates&#xD;
      predicting change in PTSD-symptoms. Finally, the T2 levels of metacognition, strategies,&#xD;
      burnout, worry about job and economy, interpersonal problems as constant covariates will be&#xD;
      added, together with the interactions of these constant covariates with time. These&#xD;
      interactions represent tests of H2 about the change in the covariates from T1 to T2&#xD;
      predicting change in PTSD-symptoms from T1 to T2s.&#xD;
&#xD;
      Transformations Depending on degree of skewness compared to theoretical possibilities and&#xD;
      interpretations, variables will be assessed in their original and validated format as is&#xD;
      recommended practice, as long as this is possible. As this study examines psychopathology&#xD;
      levels amongst a general population (and not a clinical population), we do expect a skewed&#xD;
      data PTSD-symptoms on depressive and anxiety levels with most individuals reporting low&#xD;
      levels of PTSD -symptoms.&#xD;
&#xD;
      We will attempt to assess these variables in their original and validated format as is&#xD;
      recommended practice, as long as this is possible. However, if this is not possible to the&#xD;
      statistical assumptions behind the analyses, transformation may be needed to apply&#xD;
      interval-based methods. Alternatively a non-parametric test will be used.&#xD;
&#xD;
      Inference criteria&#xD;
&#xD;
      Given the large sample size in this study, we pre-define our significance level:&#xD;
&#xD;
      p &lt; 0.01 to determine significance&#xD;
&#xD;
      Data exclusion:&#xD;
&#xD;
      All health care or public service provides above 18 are included in this study. Vulnerable&#xD;
      health-care or public service providers - in this sample defined as doctors, nurses,&#xD;
      psychologists, and any other health-care workers, as well as politicians and social workers.&#xD;
      The participants reported if they worked directly or indirectly with COVID-19 patients.&#xD;
&#xD;
      Exploratory:&#xD;
&#xD;
      Questions addressed in the future paper which is not pre-specified will be defined as&#xD;
      exploratory.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 22, 2020</start_date>
  <completion_date type="Anticipated">July 13, 2020</completion_date>
  <primary_completion_date type="Anticipated">July 13, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>PTSD Checklist for DSM-5 (PCL-5)</measure>
    <time_frame>Data is set to be collected starting from 22th of June. The data collection period will last no longer than three weeks depending on the response to the questionnaire</time_frame>
    <description>PCL-5 is a 20-item self-administered questionnaire which assesses the full domain of the DSM-5 PTSD diagnosis. The self-report rating scale is 0-4 for each symptom. Rating scale descriptors are: &quot;Not at all,&quot; &quot;A little bit,&quot; Moderately,&quot; &quot;Quite a bit,&quot; and &quot;Extremely.&quot;The PCL-5 has four subscales, corresponding to each of the symptom clusters in the DSM-5.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient Health Questionnaire 9 (PHQ-9)</measure>
    <time_frame>Data is set to be collected starting from 22th of June. The data collection period will last no longer than three weeks depending on the response to the questionnaire</time_frame>
    <description>The Patient Health Questionnaire 9 (PHQ-9; Kroenke, Spitzer &amp; Williams, 2001) is used to measure symptoms of depression in accordance with the diagnostic criteria for major depressive disorder. The questionnaire consists of nine items where each is scored on a four-point Likert scale (0-3), with the range of scores from 0 to 27.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Generalized Anxiety Disorder 7 (GAD-7)</measure>
    <time_frame>Data is set to be collected starting from 22th of June. The data collection period will last no longer than three weeks depending on the response to the questionnaire</time_frame>
    <description>The Generalized Anxiety Disorder 7 (GAD-7; Spitzer, Kroenke, Williams &amp; LÃ¶we, 2006) is a questionnaire consisting of seven items measuring symptoms of anxiety and worry. The items are scored on a four-point Likert scale (0-3), with the scores ranging from 0 to 21.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)</measure>
    <time_frame>Data is set to be collected starting from 22th of June. The data collection period will last no longer than three weeks depending on the response to the questionnaire</time_frame>
    <description>WEMWBS short version consist of 7 items</description>
  </secondary_outcome>
  <enrollment type="Anticipated">889</enrollment>
  <condition>Post Traumatic Stress Disorder</condition>
  <condition>Anxiety</condition>
  <condition>Depression</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Vulnerable health-care or public service providers was in this sample defined as doctors,&#xD;
        nurses, psychologists, and any other health-care workers, as well as politicians and social&#xD;
        workers. The participants reported if they worked directly or indirectly with COVID-19&#xD;
        patients.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Health care or public service providers above 18&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  None&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Omid Ebrahimi, Mr</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Oslo &amp; Modum Bad</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Asle Hoffart, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Oslo &amp; Modum Bad</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sverre Urnes Johnson, PhD</last_name>
    <phone>+47 41633313</phone>
    <email>sverreuj@psykologi.uio.no</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Omid Ebrahimi</last_name>
    <email>omideb@uio.no</email>
  </overall_contact_backup>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>June 19, 2020</study_first_submitted>
  <study_first_submitted_qc>June 19, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 22, 2020</study_first_posted>
  <last_update_submitted>June 22, 2020</last_update_submitted>
  <last_update_submitted_qc>June 22, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Oslo</investigator_affiliation>
    <investigator_full_name>Sverre Urnes Johnson</investigator_full_name>
    <investigator_title>Associate Professer Sverre Urnes Johnson</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stress Disorders, Traumatic</mesh_term>
    <mesh_term>Stress Disorders, Post-Traumatic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

